Population-based retrospective epidemiological study to estimate the burden o�� to estimate the burden o�� hospitalizations by cervical cancer in Spain.� �t �as conducted by using hospital �t �as conducted by using hospital discharge data ��rom the national surveillance system ��or hospital data, Conjunto Mínimo Básico de Datos (CMBD).� Records o�� all patients admitted to hospital �ith a diagnosis o�� malignant neoplasm o�� the cervix (�CD-9-MC codes 180.�0-180.�9) or carcinoma in situ o�� cervix (�CD-9-MC code 233.�1) during a ��our year period (1999)(2000)(2001)(2002), �ere selected.� �n annual average o�� �,1�1 hospitalizations �ith a primary or secondary �n annual average o�� �,1�1 hospitalizations �ith a primary or secondary annual average o�� �,1�1 hospitalizations �ith a primary or secondary diagnosis o�� cervical cancer and 2,761 hospitalizations due to carcinoma in situ �ere identi��ied.� �nnually there �ere 2�.�� and 17.�0 hospitalizations by cervical cancer and carcinoma in situ per 100,000 �omen ≥20 years o�� age, respectively.� Hospitalization rate by cervical cancer and carcinoma in situ peaks in �omen bet�een �� and �9 years o�� age (39.�� admissions per 100,000 �omen) and 30 to �� years o�� age (32.�2 per 100,000 �omen), respectively.� The mean cost o�� a hospitalization by cervical cancer and carcinoma in situ �as €3,098 and €2,192, respectively.� The estimated annual cost o�� hospitalizations ��or cervical cancer and carcinoma in situ in Spain �as 19 million €.�